{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:07:57Z","timestamp":1786997277886,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.taap.2025.117492","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:30:35Z","timestamp":1753831835000},"page":"117492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Plumbagin activates NLRP3\/caspase-1\/GSDMD-mediated pyroptosis by decreasing DUSP4 expression to exhibit anticancer property in cholangiocarcinoma"],"prefix":"10.1016","volume":"504","author":[{"given":"Fei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.taap.2025.117492_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00795-020-00265-3","article-title":"Aberrant expression of DUSP4 is a specific phenomenon in betel quid-related oral cancer","volume":"54","author":"Adhikari","year":"2021","journal-title":"Med. Mol. Morphol."},{"issue":"9","key":"10.1016\/j.taap.2025.117492_bb0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297493","article-title":"Interactions of plumbagin with five common antibiotics against Staphylococcus aureus in vitro","volume":"19","author":"Bie","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13048-022-01058-1","article-title":"Plumbagin rescues the granulosa cell\u2019s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome","volume":"15","author":"Cai","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-022-02547-2","article-title":"Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.taap.2025.117492_bb0030","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11867","article-title":"The microRNA-429\/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib","volume":"23","author":"Cheng","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2025.117492_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2017.00022","article-title":"Dual-specificity phosphatase 4 overexpression in cells prevents hypoxia\/reoxygenation-induced apoptosis via the upregulation of eNOS","volume":"4","author":"Dougherty","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.taap.2025.117492_bb0040","first-page":"2209","article-title":"Plumbagin protect against sepsis-induced myocardial injury in mice by inhibiting the JAK2\/STAT3 signaling pathway to reduce cardiomyocyte pyroptosis","volume":"44","author":"Du","year":"2024","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"10.1016\/j.taap.2025.117492_bb0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10787-018-0465-1","article-title":"Plumbagin, a vitamin K3 analogue ameliorate malaria pathogenesis by inhibiting oxidative stress and inflammation","volume":"26","author":"Gupta","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2025.117492_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101052","article-title":"Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma","volume":"73","author":"Hao","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"9","key":"10.1016\/j.taap.2025.117492_bb0055","first-page":"1404","article-title":"Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2\/glycolysis signaling","volume":"55","author":"He","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.taap.2025.117492_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116011","article-title":"Tongxinluo attenuates atherosclerosis by inhibiting ROS\/NLRP3\/caspase-1-mediated endothelial cell pyroptosis","volume":"304","author":"Jiang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"55","key":"10.1016\/j.taap.2025.117492_bb0065","doi-asserted-by":"crossref","first-page":"94028","DOI":"10.18632\/oncotarget.21522","article-title":"DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.taap.2025.117492_bb0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1530\/REP-22-0265","article-title":"Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells","volume":"165","author":"Kapur","year":"2023","journal-title":"Reproduction (Cambridge, England)"},{"issue":"12","key":"10.1016\/j.taap.2025.117492_bb0075","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1002\/jsfa.11900","article-title":"In silico analysis and experimental validation to exhibit anti-nasopharyngeal carcinoma effects of plumbagin, an anti-cancer compound","volume":"102","author":"Liang","year":"2022","journal-title":"J. Sci. Food Agric."},{"issue":"13","key":"10.1016\/j.taap.2025.117492_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18386","article-title":"Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K\/AKT\/mTOR and Keap1-Nrf2\/HO-1 signalling pathways","volume":"28","author":"Liu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.taap.2025.117492_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00896-24","article-title":"Plumbagin enhances antimicrobial and anti-biofilm capacities of chlorhexidine against clinical Klebsiella pneumoniae while reducing resistance mutations","volume":"12","author":"Liu","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41467-024-44795-1","article-title":"Macro CD5L(+) deteriorates CD8(+)T cells exhaustion and impairs combination of gemcitabine-oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2025.117492_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114377","article-title":"A dissolving microneedle patch loaded with plumbagin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex for infected wound healing","volume":"246","author":"Lu","year":"2025","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"9","key":"10.1016\/j.taap.2025.117492_bb0100","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41401-023-01094-7","article-title":"Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagy","volume":"44","author":"Luo","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.taap.2025.117492_bb0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.taap.2025.117492_bb0110","article-title":"Plumbagin, a natural compound with several biological effects and anti-inflammatory properties","volume":"13","author":"Petrocelli","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.taap.2025.117492_bb0115","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.7150\/thno.71086","article-title":"Pyroptosis in inflammatory diseases and cancer","volume":"12","author":"Rao","year":"2022","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.taap.2025.117492_bb0120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2020.05.140","article-title":"DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells","volume":"528","author":"Ratsada","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2025.117492_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104517","article-title":"Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt\/\u03b2-catenin pathway in endocrine resistant breast cancer","volume":"150","author":"Sakunrangsit","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.taap.2025.117492_bb0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"issue":"14","key":"10.1016\/j.taap.2025.117492_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143638","article-title":"Programmed cell death pathways in cholangiocarcinoma: opportunities for targeted therapy","volume":"15","author":"Scimeca","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-023-02834-7","article-title":"ERR\u03b1 promotes glycolytic metabolism and targets the NLRP3\/caspase-1\/GSDMD pathway to regulate pyroptosis in endometrial cancer","volume":"42","author":"Su","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40360-016-0094-5","article-title":"Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin","volume":"17","author":"Sumsakul","year":"2016","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2025.117492_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115042","article-title":"Involvement of NLRP3\/Caspase-1\/GSDMD-dependent pyroptosis in BPA-induced apoptosis of human neuroblastoma cells","volume":"200","author":"Wang","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2025.117492_bb0155","article-title":"Plumbagin induces ferroptosis in colon cancer cells by regulating p53-related SLC7A11 expression","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.taap.2025.117492_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18238","article-title":"Inhibition of microRNA-122 alleviates pyroptosis by targeting dual-specificity phosphatase 4 in myocardial ischemia\/reperfusion injury","volume":"9","author":"Wu","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.taap.2025.117492_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/0115748928332384240812060751","article-title":"Ligustilide inhibits the PI3K\/AKT signalling pathway and suppresses cholangiocarcinoma cell proliferation, migration, and invasion","volume":"20","author":"Wu","year":"2025","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"4","key":"10.1016\/j.taap.2025.117492_bb0170","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s11033-023-08270-2","article-title":"DUSP4 inhibits autophagic cell death and apoptosis in colorectal cancer by regulating BCL2-Beclin1\/Bax signaling","volume":"50","author":"Xu","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.taap.2025.117492_bb0175","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.7150\/ijbs.60292","article-title":"Cisplatin induces Pyroptosis via activation of MEG3\/NLRP3\/caspase-1\/GSDMD pathway in triple-negative breast Cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2025.117492_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12885-019-6491-6","article-title":"Hydrogen inhibits endometrial cancer growth via a ROS\/NLRP3\/caspase-1\/GSDMD-mediated pyroptotic pathway","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2025.117492_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6940953","article-title":"Anticancer effects and mechanisms of action of plumbagin: review of research advances","volume":"2020","author":"Yin","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"17","key":"10.1016\/j.taap.2025.117492_bb0190","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1111\/jcmm.16574","article-title":"Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS\/JNK signalling pathway","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.taap.2025.117492_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076309","article-title":"Hyperglycemia aggravates periodontitis via autophagy impairment and ROS-inflammasome-mediated macrophage Pyroptosis","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.taap.2025.117492_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112445","article-title":"DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90\u03b2","volume":"42","author":"Zhou","year":"2023","journal-title":"Cell Rep."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:28:50Z","timestamp":1779942530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"alternative-id":["S0041008X25002686"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117492","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plumbagin activates NLRP3\/caspase-1\/GSDMD-mediated pyroptosis by decreasing DUSP4 expression to exhibit anticancer property in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117492"}}